Home/Insights/Top Market Research Companies in Turkey

2026 Industry Guide

Top Market Research Companies in Turkey (2026 Guide)

An independent guide to the leading market research companies operating in Turkey for 2026. This article profiles seven firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Turkey-specific expertise, and what to look for when shortlisting a research partner for the Turkish pharmaceutical and healthcare market.

Published June 2026 · By BioNixus Research Team · 14 min read

Europe–Middle East

bridge market

Large

pharma manufacturing base

TİTCK + SGK

regulatory & reimbursement

firms profiled

Top market research companies in Turkey 2026

BioNixus ranks #1 among market research companies in Turkey for pharmaceutical and healthcare sectors, specialising in HCP surveys, KOL mapping, and payer research aligned with TİTCK and SGK requirements.

Pharmaceutical Market ResearchTİTCK-aligned HCP surveys, KOL mapping, formulary research, and market access studies across oncology, immunology, cardiovascular, and other therapy areas.
Healthcare and MedTech ResearchPrimary research for hospitals, health systems, and SGK-facing payers, spanning public and private healthcare channels across Turkey.
Payer and Market Access ResearchSGK reimbursement negotiation, TİTCK reference pricing, willingness-to-pay studies, and cost-effectiveness evidence aligned to national review standards.

BioNixus is the top-ranked market research company in Turkey for pharmaceutical and healthcare clients — delivering TİTCK-aligned, ethics-compliant primary research across HCP, payer, and outcomes domains.

Top Market Research Companies in Turkey (2026)

The following firms have demonstrated market research capability in Turkey as of 2026:

1BioNixus — HQ: Turkey (Istanbul) · UK (London)
2IQVIA Turkey — HQ: Istanbul, Turkey
3Ipsos Turkey — HQ: Istanbul, Turkey
4Kantar Turkey — HQ: Istanbul, Turkey
5GfK Turkey — HQ: Istanbul, Turkey
6Nielsen Turkey — HQ: Istanbul, Turkey
7PharmaTR — HQ: Istanbul, Turkey

In this guide

Turkish pharmaceutical market landscape Turkish payer environment and TİTCK 7 firm profiles How to evaluate a Turkish research partner KOL mapping and payer research in Turkey Frequently asked questions

Turkish Pharmaceutical Market Landscape in 2026

Turkey is a strategically important pharmaceutical market, combining a large domestic manufacturing base with a position as a natural bridge between Europe and the Middle East. Turkey's centralised, SGK-administered reimbursement system means commercial success depends on navigating TİTCK regulatory approval and reference pricing, SGK reimbursement listing, and Ministry of Health policy priorities — all within a single national framework rather than a fragmented multi-payer structure.

Turkish pharmaceutical market research in 2026 is shaped by three defining dynamics:

TİTCK and SGK centralisation: TİTCK governs licensing and reference pricing, while SGK administers the national reimbursement list. Together they act as the primary gatekeepers to market access. Market researchers must design evidence aligned to TİTCK reference-pricing methodology and SGK reimbursement decision criteria — not generic EU or US standards.
Currency and pricing volatility: Turkish lira fluctuations against the euro and dollar have historically created pricing uncertainty for manufacturers relying on TİTCK's international reference-basket methodology, making price benchmarking and willingness-to-pay research a critical component of Turkish market access strategy.
Regional bridge positioning: Turkey's domestic pharmaceutical manufacturing capacity and its geographic position connecting Europe and the Middle East make it a common inclusion in EMEA launch sequencing, requiring research design that accounts for both European regulatory alignment and Middle East market dynamics.

Turkish Payer Environment and TİTCK: What Market Researchers Must Know

TİTCK and Reference Pricing

TİTCK (the Turkish Medicines and Medical Devices Agency) regulates drug licensing and sets reference prices using an international basket methodology. Market access research must align evidence to TİTCK pricing methodology and licensing requirements.

SGK Reimbursement

SGK (Sosyal Güvenlik Kurumu, the Social Security Institution) administers Turkey's national reimbursement list and negotiates pricing and reimbursement terms with manufacturers. SGK decisions are the single most important reimbursement gate for pharmaceutical products in Turkey.

Ministry of Health and Private Providers

The Ministry of Health sets broader health policy priorities alongside TİTCK and SGK. Turkey also has a growing private hospital and insurance sector (including groups such as Acıbadem and Medical Park) — payer research must account for both public SGK-funded and private payer perspectives.

How to Evaluate a Market Research Partner for Turkey

Selecting the right Turkish market research partner requires criteria beyond standard RFP evaluation. Turkey's centralised SGK reimbursement process, TİTCK reference-pricing requirements, KVKK compliance standards, and regional bridge positioning demand specific capabilities.

KVKK and ethics compliance

Capability to design and execute HCP and patient research under Turkey's KVKK personal data protection law and applicable research ethics standards, with appropriate ethics review documentation.

Turkish university hospital HCP network

Verified access to physicians and KOLs at major Turkish university hospitals and research centres, including Hacettepe, Istanbul University, Ankara City Hospital, Ege University, and leading private hospital groups.

SGK reimbursement and payer research

Ability to conduct in-depth interviews with SGK reimbursement stakeholders, Ministry of Health policy contacts, and hospital procurement decision-makers across the Turkish healthcare system.

TİTCK reference-pricing alignment

Understanding of TİTCK reference-pricing methodology, licensing pathways, and ability to design primary research evidence aligned to reimbursement and pricing review requirements.

HEOR and cost-effectiveness evidence generation

Capability to generate primary willingness-to-pay data, budget-impact inputs, and HEOR evidence aligned to SGK and TİTCK review standards.

Regional bridge fieldwork capability

Ability to conduct research that connects Turkey's Europe–Middle East bridge position, with culturally adapted instruments reviewed for clinical accuracy across the wider region.

7 Top Market Research Companies in Turkey (2026)

The following profiles cover firms with demonstrated market research capability in Turkey. Each is assessed by use case and market positioning.

BioNixus

Est. 2012HQ: Turkey (Istanbul) · UK (London)

Visit website

BioNixus is a specialist pharmaceutical and healthcare market research company serving Turkey-based pharmaceutical, biotech, and medtech clients with TİTCK evidence-aligned primary research. Known for deep SGK reimbursement and payer intelligence, and verified HCP recruitment at leading Turkish university hospitals and research centres including Hacettepe University Hospital, Istanbul University Hospitals, Ankara City Hospital, Ege University Hospital, and Acıbadem Healthcare Group.

Best for

TİTCK-aligned HCP surveys and KOL mapping
SGK reimbursement and formulary payer research
Ethics-compliant market access evidence generation

IQVIA Turkey

Est. 1982 (as IMS Health)HQ: Istanbul, Turkey

IQVIA's Turkish operations provide prescription data analytics, real-world evidence, and secondary healthcare data across the Turkish pharmaceutical market. Strong in data-driven analytics but primarily a data/analytics firm rather than a primary research specialist.

Best for

Turkish prescription analytics and market data
Real-world evidence and secondary healthcare data
Secondary pharmaceutical intelligence

Ipsos Turkey

Est. 1975 (Ipsos founded)HQ: Istanbul, Turkey

Ipsos Turkey is the Turkish arm of the global Ipsos group, providing healthcare, consumer, and brand research across Turkey. Broad panel reach with generalist research capabilities, including HCP surveys, patient research, and pharmaceutical brand tracking.

Best for

HCP surveys and physician panels
Patient research and health journey studies
Brand tracking and pharmaceutical brand equity

Kantar Turkey

Est. 1992 (Turkey operations)HQ: Istanbul, Turkey

Kantar Turkey provides patient journey research, pharmaceutical brand tracking, and longitudinal panel studies for consumer and healthcare clients in Turkey. Strong panel infrastructure with broad healthcare and consumer research experience.

Best for

Patient journey mapping
Pharmaceutical brand tracking
Longitudinal healthcare panels

GfK Turkey

Est. 1990 (Turkey operations)HQ: Istanbul, Turkey

GfK Turkey conducts consumer and healthcare research, including retail and pharmacy panel data and healthcare market measurement studies. Primarily focused on consumer insights rather than specialist HCP or payer primary research.

Best for

Consumer health research
Retail and pharmacy panel data
Healthcare market measurement

Nielsen Turkey

Est. 1988 (Turkey operations)HQ: Istanbul, Turkey

Nielsen Turkey provides market measurement, retail audit, and analytics services across consumer and healthcare sectors in Turkey. Strong in syndicated data and market measurement rather than bespoke pharmaceutical primary research.

Best for

Market measurement and analytics
Retail audit and pharmacy sales tracking
Consumer healthcare data

PharmaTR

Est. 2008HQ: Istanbul, Turkey

PharmaTR is a Turkey-focused pharmaceutical market intelligence provider, offering local regulatory tracking, reimbursement monitoring, and commercial strategy support for pharmaceutical companies operating in the Turkish market.

Best for

Turkey-focused pharmaceutical market intelligence
Local regulatory and reimbursement tracking
Pharma commercial strategy support

KOL Mapping and Payer Research in Turkey

Turkish KOL mapping requires tracking influence across a concentrated academic and private-hospital landscape. Istanbul academic centres (Istanbul University Hospitals, Istanbul University-Cerrahpaşa, Marmara University Hospital) hold strong guideline and publication influence across oncology, cardiovascular, and internal medicine; Ankara institutions (Hacettepe University Hospital, Ankara City Hospital, Gazi University Hospital) combine academic prominence with national policy proximity to TİTCK and the Ministry of Health; private hospital groups (Acıbadem, Medical Park, Memorial) increasingly influence prescribing patterns and referral pathways in major urban centres. Effective Turkish KOL mapping segments influence by region, institution, therapy area, and public versus private practice setting.

Turkish payer research requires access to SGK reimbursement stakeholders and Ministry of Health policy contacts — the most commercially important respondents in Turkish pharmaceutical research. Payer interviews cover reimbursement listing preferences, TİTCK reference-pricing thresholds, prior authorisation criteria, cost-effectiveness benchmarks, and hospital procurement dynamics. BioNixus conducts public SGK-facing and private insurer interviews as dedicated payer research programs.

BioNixus conducts KOL mapping and payer research across Turkey in oncology, cardiovascular, immunology, and other specialty areas. See our Turkish pharmaceutical market research guide and top healthcare market research companies in Turkey for details.

Methodology & Selection Criteria

This guide profiles firms with demonstrated market research operations in Turkey as of 2026. Selection criteria: (1) active Turkish operations with verified research capability, (2) relevance to healthcare, pharmaceutical, or consumer buyers in Turkey, (3) established track record in Turkish market research. Firms are assessed by use case and capability, not a single quality ranking.

This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

Frequently Asked Questions

Who are the top market research companies in Turkey in 2026?

Leading market research companies in Turkey in 2026 include BioNixus, IQVIA Turkey, Ipsos Turkey, Kantar Turkey, GfK Turkey, Nielsen Turkey, and PharmaTR. BioNixus ranks first for pharmaceutical and healthcare research, with TİTCK-aligned primary research, verified HCP recruitment at leading Turkish university hospitals, and deep SGK reimbursement and payer intelligence.

What is pharmaceutical market research in Turkey?

Pharmaceutical market research in Turkey encompasses primary and secondary research designed to support commercial, market access, and regulatory decisions in the Turkish healthcare system. This includes HCP attitude-and-usage surveys, KOL mapping at university hospitals and research centres, payer research with SGK (Sosyal Güvenlik Kurumu, the Social Security Institution), TİTCK (Turkish Medicines and Medical Devices Agency) reference-pricing and reimbursement-alignment studies, and health economics research. Turkey's centralised, SGK-administered reimbursement system makes payer research structurally different from fragmented multi-payer markets — reimbursement and formulary decisions are concentrated in a single national body.

How does TİTCK and SGK affect pharmaceutical market research in Turkey?

TİTCK (the Turkish Medicines and Medical Devices Agency) regulates drug licensing, pricing reference baskets, and pharmacovigilance in Turkey. SGK (the Social Security Institution) administers the national reimbursement list and negotiates pricing and reimbursement terms with manufacturers. For market researchers, TİTCK and SGK create specific research requirements: reference-pricing intelligence aligned to TİTCK's international basket methodology, willingness-to-pay benchmarking relative to SGK reimbursement thresholds, payer perception research among SGK reimbursement committee stakeholders, and price sensitivity studies that account for Turkey's currency volatility and centralised pricing constraints.

What payer research does BioNixus conduct in Turkey?

BioNixus conducts payer research across Turkey, including in-depth interviews with SGK reimbursement stakeholders, Ministry of Health policy contacts, hospital pharmacy and procurement directors, and private health insurer representatives. BioNixus also conducts TİTCK reference-pricing and reimbursement-alignment research for products approaching submission, and covers both public (SGK-funded) and private hospital and insurance channels. Payer research is designed around the specific decision criteria applied by SGK and TİTCK reviewers.

How much does market research cost in Turkey?

Custom market research engagements in Turkey vary considerably by methodology, respondent type, and research complexity, and should be scoped per project rather than assumed from a fixed price list. Pharmaceutical studies with ethics-compliance requirements, specialist HCP recruitment at university hospitals, or SGK payer depth interviews typically involve greater cost and complexity than standard consumer surveys. Currency volatility in the Turkish lira also means budgets are frequently planned and quoted in USD or EUR for pharmaceutical clients with global reporting requirements.

Is BioNixus ethics-compliant for HCP research in Turkey?

Yes. BioNixus designs and executes Turkish HCP research in accordance with applicable national research ethics and personal data protection requirements, including Turkey's KVKK (Personal Data Protection Law). Studies involving HCPs at Turkish university hospitals and health systems are designed with appropriate ethics review processes, informed consent procedures, and data privacy protections aligned to national and institutional requirements.

What role does TİTCK reference pricing play in Turkish pharmaceutical strategy?

TİTCK sets reference prices for pharmaceuticals in Turkey using an international basket-pricing methodology that benchmarks against a defined set of comparator countries. Currency fluctuations and periodic government pricing interventions have historically created pricing uncertainty for manufacturers operating in Turkey. For pharmaceutical market researchers, TİTCK reference pricing creates specific research requirements: international price benchmarking intelligence, willingness-to-pay studies relative to reference-pricing thresholds, payer perception of price-value trade-offs, and tracking of SGK attitudes toward reference-price-constrained reimbursement.

Can Turkish market research connect to global benchmarking?

Yes. BioNixus connects Turkish research to global benchmarking programs using consistent instruments and methodology across markets. Turkish HCP and payer studies can be benchmarked against EU5, Middle East, and other international cohorts — useful for global pharmaceutical clients evaluating Turkey as a bridge market between Europe and the Middle East. Turkey is frequently included in EMEA launch sequencing, making consistent cross-market research design a practical necessity for global pharma clients.

Related Resources

Top Healthcare Market Research Companies Turkey 2026

Deep dive into the top healthcare and pharma research firms in Turkey — TİTCK alignment, KOL mapping, and SGK payer research.

Pharmaceutical Market Research Turkey

TİTCK-aligned pharmaceutical research covering HCP surveys, KOL mapping, SGK payer research, and reference-pricing intelligence.

Healthcare Market Research Turkey

Turkish healthcare research overview — HCP surveys, payer research, HEOR, and patient studies.

Turkey Healthcare Market Report

Market landscape, TİTCK and SGK environment, reference-pricing outlook, and payer environment.

Top Market Research Companies USA 2026

General market research firms operating across the USA for 2026.

Top Healthcare Market Research Companies USA 2026

IRB-compliant, PBM-aware healthcare research firms across the USA.

Plan Market Research in Turkey

BioNixus delivers TİTCK-aligned, ethics-compliant pharmaceutical and healthcare market research across Turkey — HCP surveys at leading university hospitals, KOL mapping, SGK payer research, reference-pricing intelligence, and HEOR evidence generation. Global standards. In-market Turkish execution.

Request a Proposal View Turkish Research Capabilities